Phase
Condition
Diabetes And Hypertension
Diabetes Prevention
Diabetes Mellitus, Type 2
Treatment
Continuous glucose monitoring
Dietetic support
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Aged 18+ years
Reside anywhere in Australia and have a postal address
Confirmed T2D diagnosis by a GP/endocrinologist
Current HbA1c of ≥7.0%
Have a smartphone and able to independently use it
Exclusion
Exclusion Criteria:
Under the age of 18 years
Use of insulin therapy (within the last three months) or medications which interferewith blood glucose levels (i.e. steroids)
Use of CGM within the last six months
Eating Disorder Examination Questionnaire (EDE-Q) global score >2.8 OR global score > or equal to 1.52, with sum of Q14-18 > or equal to 4
Currently having ongoing consultations with an APD or have had a consult with an APD (within last three months)
Not weight stable (>5 kg change over last three months)
Severe hypoglycaemic event (i.e. requiring assistance) within last six months
Change of antihyperglcyaemic medications within last three months
Women who are pregnant or breastfeeding (within 24 weeks)
History of psychotic disorder, or current diagnosis of other major psychiatricillness (e.g. mood disorder, eating disorder, substance use disorder)
History of blood disorders (including but, not limited to, anemia and thalassemia)that impact the primary outcome (HbA1c)
Study Design
Study Description
Connect with a study center
Australian Catholic University
Melbourne, Victoria 3065
AustraliaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.